Shalby secures ₹129.70 crore working capital line from Kotak

2 min read     Updated on 30 Jul 2026, 09:06 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Shalby Limited approved ₹129.70 crore in working capital facilities from Kotak Mahindra Bank, with ₹119.70 crore allocated to its US subsidiary and ₹10 crore for domestic use. The Board confirmed no material financial impact, citing arm's length terms and strategic liquidity management for overseas operations.

powered bylight_fuzz_icon
46971378

*this image is generated using AI for illustrative purposes only.

Shalby Limited has secured working capital facilities aggregating up to ₹129.70 crore from Kotak Mahindra Bank Limited to support its operational liquidity needs, with the bulk of the funding directed toward its overseas operations. The Management Committee of Directors approved the arrangement during a meeting held on July 30, 2026, signalling continued confidence in the company’s cross-border business structure and access to institutional credit. This financing move ensures that Shalby Advanced Technologies Inc., a key overseas step-down subsidiary, has sufficient working capital to sustain its activities without straining the parent company’s immediate cash flows.

The approval was formalised pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and disclosed to the National Stock Exchange of India Ltd and BSE Limited on July 30, 2026. The disclosure also references compliance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, ensuring that all related-party transaction norms and arm’s length principles are adhered to. Tushar Shah, Vice President & Company Secretary, signed the intimation, confirming that the details have been annexed as required under the Listing Regulations.

Facility Structure and Allocation

The ₹129.70 crore facility is split between the parent entity and its US-based subsidiary, reflecting the distinct operational requirements of each unit. Shalby Advanced Technologies Inc., USA, will avail ₹119.70 crore towards its specific working capital requirements, while Shalby Limited will directly access ₹10 crore via Working Capital Demand Loan (WC DL) or Cash Credit facilities.

Entity Facility Amount Purpose
Shalby Advanced Technologies Inc., USA ₹119.70 crore Working capital requirements
Shalby Limited ₹10 crore Working Capital Demand Loan (WC DL) / Cash Credit

This bifurcation allows the subsidiary to manage its local currency obligations and supply chain needs independently, while the parent company retains a smaller, flexible credit line for domestic operational adjustments. The company stated that providing such support is in the overall interest of the group, enabling the step-down subsidiary to obtain necessary credit facilities efficiently.

Governance and Impact Assessment

The Board assessed the transaction for any potential conflicts of interest, noting that no promoter or promoter group holds an interest in this transaction beyond the corporate link with Shalby Advanced Technologies Inc. As a step-down subsidiary, SAT Inc. is the direct beneficiary, but the arrangement is deemed to be at arm’s length within the group structure. The company explicitly stated that no material financial or operational impact is foreseen from this guarantee or facility arrangement, indicating that the terms are standard and manageable within existing liquidity frameworks.

What the Numbers Show

The allocation of nearly 92% of the total facility value (₹119.70 crore out of ₹129.70 crore) to the US subsidiary highlights the significant scale of Shalby’s international operations relative to its domestic parent entity’s immediate working capital needs. This concentration suggests that the subsidiary’s cash conversion cycle or inventory requirements are substantial enough to warrant dedicated institutional backing, rather than relying solely on intercompany transfers. By securing external bank credit for the subsidiary, Shalby Limited isolates its domestic balance sheet from direct exposure to the subsidiary’s day-to-day credit fluctuations, thereby preserving financial flexibility at the holding company level.

Historical Stock Returns for Shalby

1 Day5 Days1 Month6 Months1 Year5 Years
-0.97%-1.67%-6.15%-2.95%-23.08%-16.15%

How might the heavy allocation of working capital to the US subsidiary impact Shalby Limited's future capital expenditure plans for domestic hospital expansions?

What are the potential risks to Shalby Limited's consolidated financials if the US subsidiary faces adverse currency fluctuations or regulatory changes in its operating environment?

Does this reliance on external bank credit for the subsidiary signal a shift away from internal intercompany funding, and what does this imply about the group's overall liquidity strategy?

Shalby Limited Reschedules Q1 FY27 Earnings Call to Aug 13

2 min read     Updated on 29 Jul 2026, 06:32 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Shalby Limited has moved its Q1FY27 earnings call to August 13, 2026, at 10:30 AM IST, from the original date of August 7. Hosted by Elara Securities, the call will feature top management discussing quarterly results. Investors can join via dial-in or online registration.

powered bylight_fuzz_icon
46875713

*this image is generated using AI for illustrative purposes only.

Shalby Limited has rescheduled its earnings conference call to discuss the financial results for the first quarter of fiscal year 2027 (Q1FY27). The company announced on July 29, 2026, that the call, initially scheduled for Friday, August 7, 2026, at 4:00 PM IST, will now be held on Thursday, August 13, 2026, at 10:30 AM IST. This procedural update ensures stakeholders have adequate notice to participate in the discussion regarding the latest quarterly performance.

The announcement was made via a letter to the Listing Department of the National Stock Exchange of India Ltd and the Corporate Service Department of BSE Limited. The communication references an earlier intimation dated July 16, 2026, which had confirmed the original date. Tushar Shah, Vice President and Company Secretary, signed the disclosure, requesting that the revised schedule be taken on record. The company emphasized that all other details regarding the conference call remain unchanged.

Elara Securities (India) Private Limited is hosting the conference call. The session will feature key executives from Shalby Limited providing insights into the quarter’s operational and financial highlights. The management team participating in the call includes Dr. Vikram Shah, Chairman and Managing Director; Mr. Shanay Shah, President; and Mr. Amit Kumar, Chief Financial Officer. Their presence indicates a comprehensive review of the company’s strategic direction and financial health for the period.

Other senior leaders joining the discussion include Dr. Nishita Shukla, Chief Operating Officer of Shalby Hospitals; Mr. Deepak Anand, Chief Executive Officer of Shalby MedTech; Mr. Babu Thomas, Chief Human Resources Officer; and Mr. Jigar Todi from Investor Relations. This broad representation suggests that the call will cover both hospital operations and the medical technology segment, reflecting the diversified nature of Shalby’s business model.

Investors and analysts can access the call through multiple channels. Participants may register via Diamond Pass or dial in using universal numbers such as +91 22 6280 1146. Toll-free options are available for international attendees, including the US (1 866 746 2133), UK (0 808 101 1573), Singapore (800 101 2045), Hong Kong (800 964 448), and Australia (0080014243444). The timing also accommodates global markets, starting at 06:00 AM UK time and 01:30 AM East Coast US time.

Key Details of the Earnings Call

Detail Information
Event Q1 FY27 Earnings Conference Call
New Date Thursday, August 13, 2026
Time 10:30 AM IST
Original Date Friday, August 7, 2026
Host Elara Securities (India) Private Limited
Registration Via Diamond Pass or Dial-in

The rescheduling does not alter the agenda, which remains focused on reviewing Q1FY27 earnings. Investors are advised to update their calendars accordingly to ensure participation in this critical update on Shalby’s financial trajectory.

Historical Stock Returns for Shalby

1 Day5 Days1 Month6 Months1 Year5 Years
-0.97%-1.67%-6.15%-2.95%-23.08%-16.15%

What specific operational or financial metrics from Q1FY27 are investors most anticipating given the high-level executive attendance?

How might Shalby's performance in its MedTech segment influence overall revenue growth projections for FY27?

Are there any indications of strategic capital expenditures or new hospital expansions that management plans to discuss during the call?

More News on Shalby

1 Year Returns:-23.08%